BibTex RIS Kaynak Göster

Sefriaksonun kan basıncı ile solunuma etkisi ve anajejik ile antipretik aktiviteleri

Yıl 2012, Cilt: 28 Sayı: 1, 41 - 46, 01.03.2012

Öz

Amaç: Araştırmanın amacı seftriaksonun köpeklerde kan basıncı ve solunuma etkisini aratırmaktır. Ayrıca seftriaksonun fare ve ratlarda anajezik ve antipretik etkiliği de araştırıldı.Gereç ve Yöntem: Faklı dozlarda seftriaksonun (26.66, 53.33, 106.66 mg/kg, IV) anestezi altındaki köpeklerde kan basıncı ve solunuma etkisi belirlendi. İki farklı dozda seftriaksonun ise fare ve ratlarda anajezik ve antipretik etkinliği belirlendi.Bulgular: Seftriaksonun anestezi altındaki köpeklerin kan basıncı ve solunuma etkisinin olmadığı belirlendi. Ancak seftriaksonun (260 ve 520 mg/kg) dört saat süresince analjezik ve 180 ile 360 mg/kg dozlarda sırasıyla 2.5 ve 1.5 saat süresince antipretik etkinlik gösterdiği belirlendi. Öneri: Seftriakson bakterial ve ateşli enfeksiyonlarda antibakteriyel, analjezik ve antipretik etkinliğinden dolayı tercih edilebilir.

Effect of ceftriaxone on blood pressure, respiration and its analgesic and antipyretic activities

Yıl 2012, Cilt: 28 Sayı: 1, 41 - 46, 01.03.2012

Öz

Aim: The aim of this study was to determine the effect of ceftriaxone on blood pressure and respiration in dog. In addition, analgesic and antipyretic activities of ceftriaxone were investigated in mice and rats.Materials and Methods: Effect of different doses of ceftriaxone (26.66, 53.33, 106.66 mg/kg, IV) on blood pressure and respiration rate were determined in anesthetized dogs. Analgesic and antipyretic activities of two different doses of ceftriaxone were investigated in mice and rats, respectively.Results: Ceftriaxone had no effect on blood pressure and rate of respiration in anesthetized dogs. However, ceftriaxone (260 and 520 mg/kg) had a significant analgesic effect for four hours and had a significant antipyretic effect at 2.5 and 1.5 hours at doses of 180 and 360 mg/kg, respectively.Conclusion: Ceftriaxone is preferable in bacterial infections or feverish conditions owing to its antibacterial, antipyretic and analgesic activities.

Toplam 0 adet kaynakça vardır.

Ayrıntılar

Diğer ID JA69ME27BB
Bölüm Araştırma
Yazarlar

Mohamed Aboubakr Bu kişi benim

Mossad Elsayed Bu kişi benim

Ashraf Elkomy Bu kişi benim

Yayımlanma Tarihi 1 Mart 2012
Yayımlandığı Sayı Yıl 2012 Cilt: 28 Sayı: 1

Kaynak Göster

APA Aboubakr, M., Elsayed, M., & Elkomy, A. (2012). Effect of ceftriaxone on blood pressure, respiration and its analgesic and antipyretic activities. Eurasian Journal of Veterinary Sciences, 28(1), 41-46.
AMA Aboubakr M, Elsayed M, Elkomy A. Effect of ceftriaxone on blood pressure, respiration and its analgesic and antipyretic activities. Eurasian J Vet Sci. Mart 2012;28(1):41-46.
Chicago Aboubakr, Mohamed, Mossad Elsayed, ve Ashraf Elkomy. “Effect of Ceftriaxone on Blood Pressure, Respiration and Its Analgesic and Antipyretic Activities”. Eurasian Journal of Veterinary Sciences 28, sy. 1 (Mart 2012): 41-46.
EndNote Aboubakr M, Elsayed M, Elkomy A (01 Mart 2012) Effect of ceftriaxone on blood pressure, respiration and its analgesic and antipyretic activities. Eurasian Journal of Veterinary Sciences 28 1 41–46.
IEEE M. Aboubakr, M. Elsayed, ve A. Elkomy, “Effect of ceftriaxone on blood pressure, respiration and its analgesic and antipyretic activities”, Eurasian J Vet Sci, c. 28, sy. 1, ss. 41–46, 2012.
ISNAD Aboubakr, Mohamed vd. “Effect of Ceftriaxone on Blood Pressure, Respiration and Its Analgesic and Antipyretic Activities”. Eurasian Journal of Veterinary Sciences 28/1 (Mart 2012), 41-46.
JAMA Aboubakr M, Elsayed M, Elkomy A. Effect of ceftriaxone on blood pressure, respiration and its analgesic and antipyretic activities. Eurasian J Vet Sci. 2012;28:41–46.
MLA Aboubakr, Mohamed vd. “Effect of Ceftriaxone on Blood Pressure, Respiration and Its Analgesic and Antipyretic Activities”. Eurasian Journal of Veterinary Sciences, c. 28, sy. 1, 2012, ss. 41-46.
Vancouver Aboubakr M, Elsayed M, Elkomy A. Effect of ceftriaxone on blood pressure, respiration and its analgesic and antipyretic activities. Eurasian J Vet Sci. 2012;28(1):41-6.